Epileptic medications and improving patient outcomes

Epilepsy is a chronic neurological disorder characterized by recurrent seizures, which are sudden and uncontrolled electrical disturbances in the brain. It is one of the most common neurological conditions, affecting approximately 50 million people worldwide (World Health Organization, 2019). Effective management of epilepsy is crucial, as uncontrolled seizures can lead to significant physical, psychological, and social consequences. The treatment of epilepsy primarily involves the use of antiepileptic drugs (AEDs), also known as anticonvulsants. These medications work by modulating the electrical activity in the brain, thereby reducing the occurrence and severity of seizures. Over the past several decades, research has focused on understanding the mechanisms of action, efficacy, and safety of various AEDs, as well as the factors that influence their clinical use. This study aims to provide a comprehensive review of the research literature on epileptic medications, covering key aspects such as: 1) The pharmacological mechanisms of action of AEDs; 2) The efficacy and safety profiles of established and newer AEDs; 3) Factors influencing the selection and use of AEDs, including patient characteristics, comorbidities, and drug interactions; 4) Emerging trends and future directions in the development and utilization of epileptic medications.